Researchers have demonstrated an integrated technique for monitoring specific biomolecules.
Undergraduate students from around the United States spent their summer learning about cell manufacturing.
Lizanne DeStefano, executive director of the Georgia Tech Center for Education Integrating Science, Mathematics, and Computing, is one of 18 members of the inaugural STEM Education Advisory Panel of the National Science Foundation.
On June 6, Georgia Tech dedicated a Good Manufacturing Practice (GMP) like ISO 8 and ISO 7 facility.
Petit Institute executive director among Georgia Tech winners at annual life sciences industry gala
A $20 million engineering research center will help expand the uses of cell-based therapies.
In The News
Researchers have demonstrated an integrated technique for monitoring specific biomolecules -- such as growth factors -- that could indicate the health of living cell cultures produced for the burgeoning field of cell-based therapeutics.
Dr. Carl June, introduced as “the cancer slayer” at an immunotherapy conference here, challenged scientists to be far more aggressive about pushing their perspectives in the White House and Congress.
The National Science Foundation (NSF), in consultation with the Department of Education, NASA and the National Oceanic and Atmospheric Administration (NOAA) today announced the appointment of 18 members to a new advisory panel created to encourage ...
Georgia Tech Engineers created an organization to develop standards and production processes designed to mass produce life-saving cell-based therapeutics at affordable prices.
Young Dawgs prepares high school students for success
Georgia Tech - with the help of Emory, the University of Georgia and others - will create a research center to develop technology to produce therapeutic cells that it hopes will revolutionize cancer, heart disease and other research work.
A Georgia Tech-led research consortium received a nearly $20 million National Science Foundation grant to fund a new engineering research center.
NSF awards nearly $80 million for centers focused on living cell-based therapies, personalized heart tissue, point-of-care health systems and fuel derived from shale gas